NeuPath Health Inc. (NPTH.V)
- Previous Close
0.2000 - Open
0.2050 - Bid 0.2000 x --
- Ask 0.2100 x --
- Day's Range
0.2050 - 0.2100 - 52 Week Range
0.1550 - 0.2450 - Volume
25,000 - Avg. Volume
76,627 - Market Cap (intraday)
11.841M - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 14, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers, as well as legal practices through a network of health care providers comprising cardiologists, dentists, dermatologists, endocrinologists, psychiatrists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists. In addition, it operates a network of healthcare clinics and related businesses. The company is headquartered in Mississauga, Canada.
www.neupath.com148
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NPTH.V
View MorePerformance Overview: NPTH.V
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NPTH.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NPTH.V
View MoreValuation Measures
Market Cap
11.28M
Enterprise Value
19.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.16
Price/Book (mrq)
0.53
Enterprise Value/Revenue
0.27
Enterprise Value/EBITDA
6.64
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.00%
Return on Assets (ttm)
2.12%
Return on Equity (ttm)
-2.24%
Revenue (ttm)
72.81M
Net Income Avi to Common (ttm)
-728k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.92M
Total Debt/Equity (mrq)
35.81%
Levered Free Cash Flow (ttm)
5.4M